Stanford University
Showing 981-990 of 5,040 Results
-
Tami Daugherty, MD
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsDr. Daugherty is a transplant Hepatologist with full-time clinical responsibilities. She is particularly interested in the natural course and management of recurrent Hepatitis C after liver transplant, and the effect of immunosuppression on HCV recurrence.
-
Reinhold Dauskardt
Ruth G. and William K. Bowes Professor in the School of Engineering
BioDauskardt and his group have worked extensively on integrating new materials into emerging technologies including thin-film structures for nanoscience and energy technologies, high-performance composite and laminates for aerospace, and on biomaterials and soft tissues in bioengineering. His group has pioneered methods for characterizing adhesion and cohesion of thin films used extensively in device technologies. His research on wound healing has concentrated on establishing a biomechanics framework to quantify the mechanical stresses and biologic responses in healing wounds and define how the mechanical environment affects scar formation. Experimental studies are complimented with a range of multiscale computational capabilities. His research includes interaction with researchers nationally and internationally in academia, industry, and clinical practice.
-
Guido A. Davidzon
Clinical Professor, Radiology - Rad/Nuclear Medicine
BioDr. Guido Alejandro Davidzon is a Clinical Professor of Radiology in Nuclear Medicine at the Stanford University School of Medicine. He currently serves as Director of Nuclear Cardiology at Stanford Health Care and is the Chair of the Radioactive Drug Research Committee.
Dr. Davidzon is a physician-scientist, educator, and leader whose work bridges clinical innovation, academic leadership, and translational research. His research focuses on the development and clinical translation of novel radiopharmaceuticals for use in oncology, neurodegeneration, cardiology, and pain imaging. He is also actively integrating AI-driven analytics and machine learning tools into molecular imaging to advance precision diagnostics and therapeutic decision-making.
His clinical and academic efforts include advancing theranostics, PET-based biomarker discovery, and the adoption of emerging imaging technologies in patient care. Dr. Davidzon is deeply committed to mentorship and the training of the next generation of imaging specialists and nuclear medicine professionals. -
Jenna Davis
Professor of Civil and Environmental Engineering, of Environmental Social Sciences and Higgins-Magid Senior Fellow at the Woods Institute
Current Research and Scholarly InterestsProfessor Davis’ research and teaching deals broadly with the role that water plays in promoting public health and economic development, with particular emphasis on low- and middle-income countries. Her group conducts applied research that utilizes theory and analytical methods from public and environmental health, engineering, microeconomics, and planning. They have conducted field research in more than 20 countries, most recently including Zambia, Bangladesh, and Kenya.
-
Kara Davis
Associate Professor of Pediatrics (Hematology/Oncology)
Current Research and Scholarly InterestsChildhood cancers can be considered aberrations of normal tissue development. We are interested in understanding childhood cancers through the lens of normal development. Further, individual tumors are composed of heterogeneous cell populations, not all cells being equal in their ability to respond to treatment or to repopulate a tumor. Thus, we take single cell approach to determine populations of clinical relevance.
-
Mark M. Davis
Burt and Marion Avery Family Professor
Current Research and Scholarly InterestsMolecular mechanisms of lymphocyte recognition and differentiation; Systems immunology and human immunology; vaccination and infection.
-
Ronald W. Davis
Professor of Biochemistry and of Genetics
Current Research and Scholarly InterestsWe are using Saccharomyces cerevisiae and Human to conduct whole genome analysis projects. The yeast genome sequence has approximately 6,000 genes. We have made a set of haploid and diploid strains (21,000) containing a complete deletion of each gene. In order to facilitate whole genome analysis each deletion is molecularly tagged with a unique 20-mer DNA sequence. This sequence acts as a molecular bar code and makes it easy to identify the presence of each deletion.
